Navigation Links
Anthera Pharmaceuticals Announces Emerging Data from Phase 2 Open-Label Extension Study to be Presented at the ACR/ARHP 2013 Annual Scientific Meeting
Date:9/25/2013

udies with BAFF antagonists have reported the potential benefit of BAFF inhibitors in treating patients with lupus and rheumatoid arthritis.

In April 2012, Anthera completed the PEARL-SC Phase 2b clinical study to evaluate the efficacy and safety of subcutaneous blisibimod in patients with active and seropositive lupus. In June and July of 2012 Anthera announced results from PEARL-SC which led to the initiation of a Phase 3 registration plan utilizing the 200mg weekly dose of blisibimod in patients who were afflicted with active lupus despite receiving corticosteroids.

About Anthera Pharmaceuticals

Anthera Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing products to treat serious diseases associated with inflammation and autoimmune disorders.

Safe Harbor Statement

Any statements contained in this press release that refer to future events or other non-historical matters, including statements that are preceded by, followed by, or that include such words as "estimate," "intend," "anticipate," "believe," "plan," "goal," "expect," "project," or similar statements, are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements are based on the Company's expectations as of the date of this press release and are subject to certain risks and uncertainties that could cause actual results to differ materially, including but not limited to the risks and uncertainties associated with market conditions, as well as those set forth in the Company's public filings with the SEC, including the Company's Annual Report on Form 10-K for the year ended December 31, 2012 and Quarterly Report on Form 10-Q for the quarter ended June 30th, 2013. The Company disclaims any intent or obligation to update any forward-looking statements, whether because of new information, future events or otherwise, except as required by applica
'/>"/>

SOURCE Anthera Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Anthera Pharmaceuticals Reports 2013 Second Quarter Financial Results
2. Anthera Announces Initiation of BRIGHT-SC Phase 2 Clinical Study in IgA Nephropathy with Blisibimod
3. Anthera Pharmaceuticals Announces Receipt of Nasdaq Notice
4. Anthera Pharmaceuticals Announces Personnel Changes
5. Anthera Pharmaceuticals to Present at Annual Jefferies Healthcare Conference
6. Anthera Pharmaceuticals Reports 2013 First Quarter Financial Results
7. Anthera Pharmaceuticals Announces Additional Data from Phase 2b PEARL-SC Blisibimod Study
8. Anthera Refinances Existing Debt with New $20 Million Credit Facility and Secures $18.5 Million Committed Equity Financing Facility
9. Anthera Initiates CHABLIS-SC1 Phase 3 Clinical Study in Lupus with Blisibimod
10. Anthera Announces Data from the Phase 2b PEARL-SC Study Will Be Presented at the 10th International Congress on Systemic Lupus Erythematosus
11. Anthera Pharmaceuticals to Present at the 2013 Leerink Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2015)... is the daily "Profile America" feature from the U.S. ... Profile America — Tuesday, April 21st. One ... for general use this month in 1923, saving the ... is a hormone produced by the pancreas and is ... body. It was first isolated the year before by ...
(Date:4/20/2015)... 20, 2015 Actavis plc (NYSE: ... Mayr , Chief Communications Officer, will retire from ...  In conjunction with Mayr,s retirement, Alex Kelly ... of Chief Communications Officer, effective immediately. Prior to ... Vice President, Chief Communications Officer, Public Affairs and ...
(Date:4/20/2015)... , April 20, 2015   Precision Image ... series designed to highlight advances in cardiovascular imaging and ... president of the Society for Cardiovascular Magnetic Resonance ... will highlight improvements in patient management by providing broader ... presentation will help attendees to better understand appropriate use ...
Breaking Medicine Technology:U.S. Census Bureau Daily Feature for April 21 2Actavis Announces Retirement of Charles M. Mayr 2Actavis Announces Retirement of Charles M. Mayr 3Educational Webinar Teaches Improved Patient Management Through Broader Access to Cardiac MRI 2
... Decision Resources, one of the world,s leading ... finds that 98 percent of surveyed rheumatologists indicate they ... treatment of rheumatoid arthritis following the agent,s expected launch ... drug, more than 60 percent of these rheumatologists cite ...
... Arcadia Resources, Inc. (NYSE Amex: KAD ), a ... Arcadia HealthCare(SM) brand, today announced President and CEO Marvin R. ... Capital Markets Sixth Annual Healthcare Conference at 1:10 p.m. ET ... its story to institutional investors in a 25 minute presentation ...
Cached Medicine Technology:Ninety Eight Percent of Surveyed Rheumatologists Will Prescribe Roche's Actemra for Rheumatoid Arthritis 2Ninety Eight Percent of Surveyed Rheumatologists Will Prescribe Roche's Actemra for Rheumatoid Arthritis 3Arcadia Resources to Present at Lazard Healthcare Conference in New York 2
(Date:4/21/2015)... 2015 Spring and summer are popular ... visiting family for the holidays or simply taking vacations. ... to travel can be a difficult choice. Pet-friendly accommodations ... pets is becoming a more common option. Royal ... stay at pet-friendly accommodations a positive experience. , 1.) ...
(Date:4/21/2015)... CA (PRWEB) April 21, 2015 “The warm ... SunGrubbies.com. “Doesn’t every mother want to look younger than her ... is the first line of defense. Signs of ... are the evidence of too much time spent in the ... only reason to cover up. The dangers of UV ...
(Date:4/20/2015)... Virginia (PRWEB) April 20, 2015 ... Health facility in Stuarts Draft, an independent, nonprofit ... Staunton, and Waynesboro, Virginia. The project was an ... The Stuarts Draft facility is expected to provide ... Located on Stuarts Draft Highway, the new facility ...
(Date:4/20/2015)... NOVI, Mich. (PRWEB) April 21, 2015 ... sisters, daughters and girlfriends at the twentieth annual Michigan ... Collection Showplace in Novi. , “There is lots to ... cooking demonstration to shopping for fashion and gifts,” said ... three stages are entertaining and encouraging with appearances from ...
(Date:4/20/2015)... Global Lyme Alliance (GLA) announced today that its ... Hyatt Regency Greenwich, raised over $850,000 to fund research ... tick-borne diseases. , “We are extremely grateful to ... this year’s Gala such a success,” said Robert Kobre, ... initiatives to ultimately find a cure for Lyme ...
Breaking Medicine News(10 mins):Health News:Royal Flush Havanese Announces 5 Tips for a Successful Stay in Pet-Friendly Accommodations 2Health News:Royal Flush Havanese Announces 5 Tips for a Successful Stay in Pet-Friendly Accommodations 3Health News:Royal Flush Havanese Announces 5 Tips for a Successful Stay in Pet-Friendly Accommodations 4Health News:Sun’s the Word this Mother’s Day Say’s SunGrubbies.com, a Leading Retailer of Sun Protection Products 2Health News:Augusta Health Construction Wraps Up at Stuarts Draft 2Health News:Perfect Girls Day Out at Michigan International Women’s Show Opening Thursday, April 30 in Novi Presented by Southern Shows 2Health News:Perfect Girls Day Out at Michigan International Women’s Show Opening Thursday, April 30 in Novi Presented by Southern Shows 3Health News:Global Lyme Alliance's “Time for Lyme” Gala Raises Over $850,000 for Tick-Borne Disease Research 2Health News:Global Lyme Alliance's “Time for Lyme” Gala Raises Over $850,000 for Tick-Borne Disease Research 3
... Hospital and Columbia University Medical Center has led the ... HIV.// He is lead author and chair of the ... treatment of the disease in developed nations—presented on Aug. ... and published in the Aug. 16 Journal of the ...
... scientists childhood allergies are increasing around the world, even ... eczema have become serious// public health issues. ... being hospitalized or even dying. ,Although the ... inflammation of the airways, it is still unknown what ...
... maternity hospital was diagnosed with deadly whooping cough. As a ... as a precautionary measure. ,This woman was working ... in Camperdown. The Sydney South West Area Health Service had ... staff member ceased all contact with patients and families immediately,' ...
... epidemic of this season. This disease seems to have overshadowed ... the viral disease had been reported from Tamil Nadu, Karnataka, ... last 2 years. In Tamil Nadu alone, 49,567 people have ... · Aedes aegypti mosquito is 60 % higher than ...
... not to give unpasteurized apple juice or other unpasteurized products ... Even the elderly and people with weak immune systems are ... is that such products contain Salmonella and E. coli, which ... also said that a majority of juice n the country ...
... project that will test the clinical efficacy of Ayurvastra, ... herb// concoctions." The project was launched at the Government ... project was started by the Directorate of Handloom, Department ... Vijnan, Government Ayurveda College. The project aims to start ...
Cached Medicine News:Health News:Dr. Scott Hammer Authors Two New Guidelines for HIV Treatment 2Health News:World wide Increase in Childhood Allergies 2Health News:Beware of Chikungunya !! 2
Double ended with 0.5mm x 10mm and 1.0mm x 15mm blades; both blades gently curved; round serrated handle, In Titanium....
0.5mm "K" hook. Rounded knurled handle; shaft angled 11mm from tip; overall length 120mm, in Titanium....
Bend with "H" Shaped Tip, Right; Stainless Steel....
The GE e-Speed™scanner, the worlds fastest computed tomography (CT) imaging platform, delivers a new advanced tool for physicians to see and diagnose heart disease....
Medicine Products: